Is nasal high-flow therapy of value in hypercapnic COPD?
Trial pits the device against non-invasive ventilation.
Trial pits the device against non-invasive ventilation.
The effects of a beta blocker were not what the researchers expected.
Small Dutch trial shows it is as effective as hospital-based therapy.
Rebates were increased last year but they remain inadequate, the RACGP says.
Fewer antibiotics used and no deleterious effect on patients, say researchers.
Using FEV1:FVC of 0.7 in diagnosis is 'as accurate or more accurate than other thresholds', say authors.
Findings were similar for those born very underweight.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.